Access to Medicines

Don’t Be Afraid of Compulsory Licenses Despite US Threats: Special 301 Reports 1998-2017 – Listing Concern... 

Access to Medicines

Gilead Anti-Diversion Program for Hep C Medicines Throws Patient Rights under the IP Bus 

Access to Medicines

The Cynical Connectedness of Gilead’s Hepatitis C Pricing and Anti-Diversion Policies 

Access to Medicines

Gilead’s Proposed Hepatitis C Medicines License – How Badly Will it Miss the Target? 

SEE MORE